A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy
Public ClinicalTrials.gov record NCT02769780. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Nexus is a collaboration between academic institutions, advocacy and industry to answer important questions about narcolepsy. It is a web-based observational study of patient-reported outcomes in adult patients with narcolepsy, with follow-up every six months. Nexus website: www.narcolepsyregistry.com
Study identification
- NCT ID
- NCT02769780
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,500 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2015
- Primary completion
- Aug 8, 2021
- Completion
- Aug 8, 2021
- Last update posted
- Apr 4, 2022
2015 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jazz Pharmaceuticals | Palo Alto | California | 94304 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Narcolepsy trials
Other public records listing Narcolepsy. Sorted by last update posted; newest first. Not a recommendation.
- NCT07625280: A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH Recruiting
- NCT07675135: A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy Recruiting
- NCT07493265: A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy Recruiting
- NCT06383806: Decreasing Nightmares in Adults With Narcolepsy Not yet recruiting
- NCT04806620: Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research Recruiting
- NCT05536011: WAKIX® (Pitolisant) Pregnancy Registry Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02769780, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2022 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02769780 live on ClinicalTrials.gov.